أعرض في EDS

CCR Translation for This Article from HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab

التفاصيل البيبلوغرافية
العنوان: CCR Translation for This Article from HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
المؤلفون: Clifford Hudis, Alison L. Hannah, Larry Norton, Sujata Patil, Weining Ma, Steven Sugarman, Mary E. Moynahan, Maura Dickler, Gabriella D'Andrea, Neal Rosen, Sarat Chandarlapaty, David Solit, Hannah Linden, Alison Stopeck, Shanu Modi
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: CCR Translation for This Article from HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
DOI: 10.1158/1078-0432.22442405
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56faa053d339adcfa9292c777d5efbc2
https://doi.org/10.1158/1078-0432.22442405
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....56faa053d339adcfa9292c777d5efbc2
قاعدة البيانات: OpenAIRE
الوصف
DOI:10.1158/1078-0432.22442405